Joshua A. Kazam

Joshua A. Kazam, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Allogene Therapeutics, Inc., Kronos Bio, Inc. and Latch, Inc. Over a trading history stretching from 4 June 2021 to 18 June 2026, the count stands at 9 filings.

On the market, this insider has only ever bought: 1 purchase, €166k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants and 3 option exercises.

The newest entry dates from 23 June 2026: an option exercise, in Allogene Therapeutics, Inc. The last purchase on record was published on 14 January 2022, which is 1,738 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.